+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Immunoassay"

Immunoassay Systems: Global Strategic Business Report - Product Thumbnail Image

Immunoassay Systems: Global Strategic Business Report

  • Report
  • April 2024
  • 267 Pages
  • Global
From
Immunoassay Global Market Report 2024 - Product Thumbnail Image

Immunoassay Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Global Immunoassay Market 2024-2028 - Product Thumbnail Image

Global Immunoassay Market 2024-2028

  • Report
  • October 2023
  • 166 Pages
  • Global
From
From
From
In Vitro Diagnostics Business Outlook, 2024 (6 updates) - Product Thumbnail Image

In Vitro Diagnostics Business Outlook, 2024 (6 updates)

  • Report
  • January 2024
  • 33 Pages
  • Global
From
From
The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition - Product Thumbnail Image

The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition

  • Report
  • August 2023
  • 1500 Pages
  • Global
From
Loading Indicator

The Immunoassay market is a segment of the In Vitro Diagnostics (IVD) industry. Immunoassays are laboratory tests used to detect and measure the presence of antigens or antibodies in a sample. These tests are used to diagnose and monitor a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. Immunoassays are also used to detect and measure hormones, drugs, and other substances in the body. Immunoassays are typically performed in a laboratory setting, but some tests are now available for use in point-of-care settings. Immunoassays are often used in combination with other tests to provide a more comprehensive diagnosis. The Immunoassay market is highly competitive, with a number of companies offering a wide range of products. Some of the major players in the market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Ortho Clinical Diagnostics, and bioMérieux. Show Less Read more